ARCA biopharma is a biopharmaceutical company principally focused on developing genetically-targeted therapies for cardiovascular diseases. The company's key product candidate, Gencaro

Babcock & Wilcox Enterprises is a technology-based provider of fossil and renewable power generation and environmental equipment. The company has three segments: Power, which is focused on technologies and aftermarket services for steam-generating, environmental, and auxiliary equipment for power generation and other industrial applications; Renewable, which is focused on the supply of steam-generating systems, environmental and auxiliary equipment for the waste-to-energy and biomass power generation industries; and Industrial, which is focused on cooling, environmental, acoustic, emission and filtration solutions, other industrial equipment and related aftermarket services.

Carriage Services is a provider of funeral and cemetery services and merchandise. The company operates in two business segments: funeral home operations, which provide a range of services, including consultation, the removal and preparation of remains, the sale of caskets and related funeral merchandise, the use of funeral home facilities for visitation and services and transportation services; and cemetery operations, which include a range of products and services including interment services, the rights to interment in cemetery sites (primarily grave sites, mausoleum crypts and niches) and related cemetery merchandise, such as memorials and vaults.

Chembio Diagnostics and its subsidiaries develop, manufacture, and commercialize point-of-care diagnostic tests that are used to detect and diagnose diseases. The company's product commercialization and product development activities are focused on infectious disease testing and technology collaborations. In infectious disease, the company is commercializing tests for human immunodeficiency virus and Syphilis, Zika virus, and developing tests for malaria, dengue virus, chikungunya virus, ebola, lassa, Marburg, leptospirosis, Rickettsia typhi, Burkholderia pseudomallei, and Orientia tsutsugamushi, individually or as part of fever panel tests.

La Jolla Pharmaceutical is a biopharmaceutical company focused on the discovery, development and commercialization of therapies for patients suffering from life-threatening diseases. GIAPREZATM (angiotensin II) is approved by the United States Food and Drug Administration as a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock. LJPC-0118 is the company's investigational product for the treatment of severe malaria. LJPC-401 (synthetic human hepcidin), a clinical-stage investigational product, is being developed for the treatment of conditions characterized by iron overload, such as hereditary hemochromatosis, beta thalassemia and polycythemia vera.

National Health Investors is a self-managed real estate investment trust, which focuses on sale-leaseback, joint-venture, mortgage and mezzanine financing of senior housing and medical facility investments. The company's portfolio consists of real estate investments in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, nursing facilities, hospitals and medical office buildings. The company's investments are structured as acquisitions of properties through purchase-leaseback transactions, acquisitions of properties from other real estate investors, loans or operations.

NII Holdings is a holding company. Through its majority-owned Brazilian operating company, Nextel Telecomunicacoes Ltda., (Nextel Brazil), the company provides wireless communication services under the Nextel? brand in Brazil. Nextel Brazil operates a wideband code division multiple access network, which has been upgraded to provide long-term evolution services in certain areas. The services the company provides include: mobile telephone voice and wireless data services; international voice and data roaming services; other services, including sports, music and entertainment streaming capabilities; online education; and access to national and international WiFi hotspot networks.

Odonate Therapeutics is a pharmaceutical company focused on the development of therapeutics that improve and extend the lives of patients with cancer. The company's initial focus is on the development of tesetaxel, an investigational, orally administered chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer. In patients with metastatic breast cancer, tesetaxel was shown to have single-agent antitumor activity in two multicenter, Phase 2 studies. The company is conducting a multinational, multicenter, randomized, Phase 3 study in patients with locally advanced or metastatic breast cancer, known as CONTESSA.

Orion Energy Systems is engaged in providing light emitting diode lighting, wireless Internet of Things, enabled control solutions ,and energy project management. The company has three reportable segments: Orion Engineered Systems Division, which develops and sells lighting products and provides construction and engineering services for its commercial lighting and energy management systems; Orion Distribution Services Division, which focuses on selling lighting products through manufacturer representative agencies and a network of North American distributors; and Orion U.S. Markets Division, which sells commercial lighting systems and energy management systems to the wholesale contractor markets.

PennantPark Floating Rate Capital is a closed-end, externally managed, non-diversified investment company. The company's objectives is to generate both current income and capital appreciation while seeking to preserve capital by investing primarily in loans bearing a variable-rate of interest, or Floating Rate Loans, and other investments made to United States middle-market companies.

Plumas Bancorp is a bank holding company. Through its subsidiary, Plumas Bank, the company serves the financial needs of individuals and businesses. The company's retail lending services include consumer, automobile and home equity loans. The company's commercial lending services include term real estate, commercial and industrial term loans. The company also provides government- guaranteed and agricultural loans as well as credit lines. The company's deposit products for the retail and commercial banking markets including checking, interest-bearing and premium interest-bearing checking, business sweep, public funds sweep, savings, time deposit and retirement accounts, as well as remote deposit, telephone and mobile banking.

Prospect Capital is a financial services company that primarily lends to and invests in middle market privately-held companies. The company is a closed-end investment company. The company's investment objective is to generate both income and long-term capital appreciation through debt and equity investments. The company invests primarily in senior and subordinated debt and equity of private companies in need of capital for acquisitions, divestitures, growth, development, recapitalizations and other purposes.

Wesco Aircraft Holdings is a distributor and provider of supply chain management services to the global aerospace industry. The company's services range from distribution to the management of supplier relationships, quality assurance, kitting, just-in-time (JIT) delivery, chemical management services, third-party logistics or fourth-party logistics programs and point-of-use inventory management. The company supplies active stock-keeping units, including C-class hardware, chemicals, electronic components, bearings, tools and machined parts. In addition to the central stocking facilities, the company uses a network of forward-stocking locations to service its customers in a JIT and or ad hoc manner.